Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
250
NCT00895479
Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence
Phase: Phase 3
Role: Lead Sponsor
Start: Apr 30, 2009
Completion: Sep 30, 2011